Chinglin Lai
About Chinglin Lai
Chinglin Lai's Role at Apollomics
Chinglin Lai joined Apollomics in 2021 as the Senior Vice President of Biometrics and later transitioned to the role of Senior Vice President of Biostatistics and Data Management. In this position, Lai oversees the biostatistics and data management functions, contributing to the strategic direction and implementation of statistical methodologies in drug development processes.
Chinglin Lai's Professional Experience
With over 27 years of experience in drug development, Chinglin Lai has a broad understanding of various therapeutic areas. Before his current role, Lai served as a consultant, providing statistical expertise to over 20 pharmaceutical and biotech companies in the US and Asia. His experience includes leadership positions at Jazz Pharmaceuticals where he managed biostatistics, statistical programming, and data management functions for the entire product portfolio.
Chinglin Lai's Contributions to Drug Approvals
During his tenure at Alza Corporation, Chinglin Lai was instrumental in securing marketing approvals for five products in both the US and EU. His contributions played a significant role in the successful regulatory submission and market introduction of these products.
Chinglin Lai's Academic Background
Chinglin Lai holds a B.S. in Mathematics from National Central University in Taiwan. He furthered his education by earning a Ph.D. in Applied Statistics from the University of California, Riverside. His Ph.D. work focused on experimental design, equipping him with advanced analytical and statistical skills critical in his field.
Chinglin Lai's Early Career and Contributions
Chinglin Lai's early career includes a pivotal role at Intrabiotics Pharmaceuticals, where he was part of the core team evaluating in-licensing opportunities from 2004 to 2005. His efforts in the evaluation process were crucial in identifying potential assets for the company's pipeline.